Thanks for your interest in our recent webinar in partnership with The Scientist. Watch as Dr. Kevin Wang explores how matching the major TBI subphenotypes with precision medicine-based biomarkers is a promising tool for monitoring disease course, predicting patient outcome, and developing new therapies.